Tag Archives: Overtreatment

Medicalising life

Medicines have been getting into the mainstream news quite a lot in recent times. A couple of days ago saw the publication in Annals of Oncology of a review of the evidence for a protective effect of aspirin in reducing cancer in the general population. The role of aspirin in cardiovascular disease prevention is well …read more

Posted in Blog | Also tagged , , , | Group: | Comments closed

Are ACE inhibitors not as ace as we thought?

ACE inhibitors and “sartans” are the NHS’s second most commonly prescribed drugs, used to treat a range of cardiovascular problems. Work by members of CCHSR published in the journal PLOS One shows that their increasing use appears to be strongly associated with acute kidney injury.

Posted in Blog | Also tagged , , | Group: | Comments closed

Inappropriate medicines and prescribing – why it matters

Over the last year, the English NHS spent £10 billion on prescribing around a billion items in primary care. Yet a substantial amount of medication use may be potentially inappropriate. How can we as researchers potentially address this problem?

Posted in Blog | Also tagged , , , , | Group: | Comments closed

When less is more: Responding to overtreatment

There is much about medicine that is good. But as Fiona Godlee points out, it is possible to have too much of a good thing. Evidence for potential harms of overtreatment, both to individual patients and to society, should not be ignored. All treatments have the potential to do harm, as well as good. Yet …read more

Posted in Blog | Tagged | Group: | Comments closed
  • The Cambridge Centre for Health Services Research (CCHSR) is a thriving collaboration between the University of Cambridge and RAND Europe. We aim to inform health policy and practice by conducting research and evaluation studies of organisation and delivery of healthcare, including safety, effectiveness, efficiency and patient experience.